Impact News +++ Corporate News: Heidelberg Pharma AG (EQS) +++ HEIDELBERG PHARMA Aktie -5,66%

PRESTIGE CONSUMER Aktie

>Performance

1 Woche: +2,0%

1 Monat: +1,0%

3 Monate: -1,9%

6 Monate: -29,9%

1 Jahr: -34,0%

laufendes Jahr: -30,9%

>PRESTIGE CONSUMER Aktie

Name:

PRESTIGE CONSUMER HEALTHCARE

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US74112D1019 / A0DN17

Symbol/ Ticker:

PBV (Frankfurt) / PBH (NYSE)

Kürzel:

FRA:PBV, ETR:PBV, PBV:GR, NYSE:PBH

Index:

Webseite:

https://www.prestigebrand..

Profil:

Prestige Consumer Healthcare Inc. is a corporation..
>Volltext..

Marktkapitalisierung:

2516.38 Mio. EUR

Unternehmenswert:

3301.65 Mio. EUR

Umsatz:

945.88 Mio. EUR

EBITDA:

318.33 Mio. EUR

Nettogewinn:

171.07 Mio. EUR

Gewinn je Aktie:

3.46 EUR

Schulden:

886.72 Mio. EUR

Liquide Mittel:

101.45 Mio. EUR

Operativer Cashflow:

224.39 Mio. EUR

Bargeldquote:

0.88

Umsatzwachstum:

-0.02%

Gewinnwachstum:

-2.48%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Div. Historie:

27.09.18 - 0.43776€

Insiderhandel:

2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 238.050 USD.

Suchwörter:

PRESTIGE CONSUMER

Letzte Datenerhebung:

17.12.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 48.08 Mio. St.

Frei handelbar: 98.51%

Leerverk. Aktien: 3.72%

Rückkaufquote: 3.67%

Mitarbeiter: 600

Umsatz/Mitarb.: 1.62 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 27.28%

Bewertung:

KGV: 15.24

KGV lG: 13.48

KUV: 2.7

KBV: 1.62

PEG-Ratio: -

EV/EBITDA: 10.37

Rentabilität:

Bruttomarge: 54.26%

Gewinnmarge: 18.09%

Operative Marge: 31%

Managementeffizenz:

Gesamtkaprendite: 5.94%

Eigenkaprendite: 11.29%

>Peer Group

Es sind 599 Aktien bekannt.

>Chart & Kurs - NYSE

>Alle News

10.12.25 - 16:45	Implied Volatility Surging for Prestige Consumer Stock Options (Zacks)
	Investors need to pay close attention to PBH stock based on the movements in the options market lately....

09.12.25 - 15:03	Kenra Professional Launches on Sephora.com, Expanding Access to Salon Trusted Haircare for the Prestige Consumer (PR Newswire)
	LOS ANGELES, Dec. 9, 2025 /PRNewswire/ -- Kenra Professional, the #1 Professional Styling Brand in the U.S.* and a leader in professional haircare, today announced its official retail launch on Sephora.com. This partnership marks a major milestone in Kenra Professional's ongoing retail......

08.12.25 - 17:30	Wall Street Analysts Believe Prestige Consumer Healthcare (PBH) Could Rally 26.06%: Here′s is How to Trade (Zacks)
	The consensus price target hints at a 26.1% upside potential for Prestige Consumer Healthcare (PBH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term....

03.12.25 - 01:01	Insiderhandel: Senior VP Operations verkauft Aktien von Prestige Brand Holdings im Wert von 16860 USD (Insiderkauf)
	Zerillo, Jeffrey - Vorstand - Tag der Transaktion: 2025-12-01...

03.12.25 - 01:01	Insiderhandel: Senior VP Operations verkauft Aktien von Prestige Brand Holdings im Wert von 43140 USD (Insiderkauf)
	Zerillo, Jeffrey - Vorstand - Tag der Transaktion: 2025-11-28...

27.11.25 - 03:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Prestige Brand Holdings im Wert von 178050 USD (Insiderkauf)
	Byom, John E. - Aufsichtsrat - Tag der Transaktion: 2025-11-25...

06.11.25 - 21:42	Prestige Consumer Healthcare anticipates $1.1B–$1.115B in fiscal 2026 revenue as Clear Eyes supply normalizes (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.25 - 16:45	Prestige Consumer Healthcare (PBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
	The headline numbers for Prestige Consumer Healthcare (PBH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

06.11.25 - 15:15	Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates (Zacks)
	Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of +10.31% and +6.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

06.11.25 - 12:09	Prestige Consumer Healthcare Non-GAAP EPS of $1.07 beats by $0.10, revenue of $274.1M beats by $16.86M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.25 - 12:03	Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results (GlobeNewswire EN)
	TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2025....

06.10.25 - 23:03	Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results (GlobeNewswire EN)
	TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET....

19.09.25 - 16:00	Implied Volatility Surging for Prestige Consumer Stock Options (Zacks)
	Investors need to pay close attention to PBH stock based on the movements in the options market lately....

04.09.25 - 13:03

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference (GlobeNewswire EN)

TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the “Investors” section and the “Events and Presentations” tab, or by using the following link:...

08.08.25 - 08:45	Prestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recovery (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 16:45	Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
	Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

07.08.25 - 15:15	Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates (Zacks)
	Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of -5.94% and -4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...

07.08.25 - 12:12	Prestige Consumer Healthcare misses Q1 estimates, revises outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.08.25 - 14:15	TheraTears® Unveils "It′s a Science" Marketing Campaign (PR Newswire)
	TARRYTOWN, N.Y., Aug. 5, 2025 /PRNewswire/ -- TheraTears®, a leading brand in dry eye relief under Prestige Consumer Healthcare, is thrilled to announce the launch of its innovative "It's a Science" marketing campaign. This campaign highlights the science-backed formulation of TheraTears®......

15.07.25 - 14:03	Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results (GlobeNewswire EN)
	TARRYTOWN, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram